Prof. Jacob Schachter
Sheba Medical Center, Israel

Prof. Jacob Schachter received his MD in 1976 from the Hebrew University, Hadassah Medical Center, Jerusalem, and was recognized as certified specialist in Oncology in 1987. He is Professor and Head of Oncology Department in Tel-Aviv University Medical School, and director of the Ella Lemelbaum Institute for Immuno-Oncology and Skin Cancer at the Sheba Medical Center in Israel.

He published over 100 original articles in peer reviewed Journals and chapters in books on the subject of melanoma and tumor immunology, and presented his work in many world leading scientific meetings. His current medical and scientific work is concentrated on adoptive immunotherapy of melanoma patients using Tumor Infiltrating Lymphocytes (TIL) Technology, and in clinical development of modern immunotherapy technologies including check-points inhibitors.

Prof. Dr. Dirk Schadendorf
University Hospital Essen, Germany

Dirk Schadendorf is the Director of the Department of Dermatology (since 2008) and the West German Cancer Center at the University Hospital Essen (since 2013).

In 1986 he got the license to practice medicine, obtained post-doc training in Tumour Immunology at MSKCC in N.Y.. After 6 years at the University Hospital Rudolf Virchow, Berlin, he became Assistant Professor for Dermatology in 1994. He was appointed Associate Professor for Dermato-Oncology at Mannheim University Hospital, University of Heidelberg, and Head of Skin Cancer Unit, German Cancer Research Center, Heidelberg. He is currently involved in more than 30 clinical studies. He has a strong focus on translational research and has published more than 400 peer-reviewed papers.